Discovery of novel thiourea derivatives as potent and selective β3-adrenergic receptor agonists

被引：13
|
作者：
Maruyama, Tatsuya [1 ]
Seki, Norio [1 ]
Onda, Kenichi [1 ]
Suzuki, Takayuki [1 ]
Kawazoe, Souichirou [1 ]
Hayakawa, Masahiko [1 ]
Matsui, Tetsuo [1 ]
Takasu, Toshiyuki [1 ]
Ohta, Mitsuaki [1 ]
机构：
[1] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2009年 / 17卷 / 15期
关键词：
beta 3-Adrenergic receptor; Agonist; Thiourea; Phenoxypropanolamine; Diabetes; BETA(3) ADRENERGIC-RECEPTOR; HUMAN DETRUSOR MUSCLE; BETA(3)-ADRENOCEPTOR AGONISTS; OBESITY; ADRENOCEPTOR; EXPRESSION; SUBTYPES; DRUGS;
D O I：
10.1016/j.bmc.2009.06.031
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
In the search for potent and selective human beta 3-adrenergic receptor (AR) agonists as potential drugs for the treatment of obesity and noninsulin-dependent (type II) diabetes, we prepared a novel series of phenoxypropanolamine derivatives containing the thiourea moiety and evaluated their biological activities at human beta 3-, beta 2-, and beta 1-ARs. Among these compounds, 4-nitrophenylthiourea (18i) and 3-methoxyphenylthiourea (18k) derivatives were found to exhibit potent agonistic activity at the b3-AR, with EC(50) values of 0.10 and 0.16 mu M, respectively, and no agonistic activity for either the beta 1-or beta 2-AR. In addition, they showed significant hypoglycemic activity in a rodent diabetic model. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码：5510 / 5519
页数：10
相关论文
共 50 条
  • [31] Discovery of highly potent and selective biphenylacylsulfonamide-based β3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the β2-adrenergic receptor: Part 6
    Hattori, Kouji
    Orita, Masaya
    Toda, Susumu
    Imanishi, Masashi
    Itou, Shinji
    Nakajima, Yutaka
    Tanabe, Daisuke
    Washizuka, Kenichi
    Araki, Takanobu
    Sakurai, Minoru
    Matsui, Shigeo
    Imamura, Emiko
    Ueshima, Koji
    Yamamoto, Takao
    Yamamoto, Nobuhiro
    Ishikawa, Hirofumi
    Nakano, Keiko
    Unami, Naoko
    Hamada, Kaori
    Matsumura, Yasuhiro
    Takamura, Fujiko
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (16) : 4679 - 4683
  • [32] Discovery of a novel series of biphenyl benzoic acid derivatives as highly potent and selective human β3 adrenergic receptor agonists with good oral bioavailability.: Part II
    Imanishi, Masashi
    Itou, Shinji
    Washizuka, Kenichi
    Hamashima, Hitoshi
    Nakajima, Yutaka
    Araki, Takanobu
    Tomishima, Yasuyo
    Sakurai, Minoru
    Matsui, Shigeo
    Imamura, Emiko
    Ueshima, Koji
    Yamamoto, Takao
    Yamamoto, Nobuhiro
    Ishikawa, Hirofumi
    Nakano, Keiko
    Unami, Naoko
    Hamada, Kaori
    Matsumura, Yasuhiro
    Takamura, Fujiko
    Hattori, Kouji
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) : 4002 - 4020
  • [33] Novel phenylamino acetamide derivatives as potent and selective κ opioid receptor agonists
    Chu, GH
    Gu, MH
    Cassel, JA
    Belanger, S
    Stabley, GJ
    DeHaven, RN
    Conway-James, N
    Koblish, M
    Little, PJ
    DeHaven-Hudkins, DL
    Dolle, RE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (03) : 645 - 648
  • [34] Discovery of novel prostacyclin mimetics with highly potent and selective IP receptor agonists
    Hattori, Kouji
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 2006, 64 (09) : 923 - 933
  • [35] Three-dimensional QSAR and pharmacophore mapping of biphenyl benzoic acid derivatives as selective human β3-adrenergic receptor agonists
    Vikas N. Telvekar
    Dharmeshkumar J. Patel
    Nikhil C. Jadhav
    Sanket J. Mishra
    Medicinal Chemistry Research, 2010, 19 : 1174 - 1190
  • [36] The use of β3-adrenergic receptor agonists in the treatment of heart failure
    Rasmussen, Helge H.
    Figtree, Gemma A.
    Krum, Henry
    Bundgaard, Henning
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (09) : 955 - 962
  • [37] Three-dimensional QSAR and pharmacophore mapping of biphenyl benzoic acid derivatives as selective human β3-adrenergic receptor agonists
    Telvekar, Vikas N.
    Patel, Dharmeshkumar J.
    Jadhav, Nikhil C.
    Mishra, Sanket J.
    MEDICINAL CHEMISTRY RESEARCH, 2010, 19 (09) : 1174 - 1190
  • [38] MEDI 268-Discovery of a novel series of biphenyl benzoic acid derivatives as potent, selective and orally bioavailable human beta 3 adrenergic receptor agonists with a long duration
    Imanishi, Masashi
    Tomishima, Yasuyo
    Itou, Shinji
    Hamashima, Hitoshi
    Nakajima, Yutaka
    Sakurai, Minoru
    Washizuka, Kenichi
    Matsui, Shigeo
    Imamura, Emiko
    Ueshima, Koji
    Yamamoto, Takao
    Hamada, Kaori
    Takamura, Fujiko
    Hattori, Kouji
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 235
  • [39] Discovery of Novel Selective Human β3 Adrenergic Receptor Agonists as Potential Overactive Bladder (OAB) Therapies
    Imanishi, Masashi
    Hattori, Kouji
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 2011, 69 (12) : 1402 - 1410
  • [40] Discovery of novel oxazolidinedione derivatives as potent and selective mineralocorticoid receptor antagonists
    Yang, Christine
    Shen, Hong C.
    Wu, Zhicai
    Chu, Hong D.
    Cox, Jason M.
    Balsells, Jaume
    Crespo, Alejandro
    Brown, Patricia
    Zamlynny, Beata
    Wiltsie, Judyann
    Clemas, Joseph
    Gibson, Jack
    Contino, Lisa
    Lisnock, JeanMarie
    Zhou, Gaochao
    Garcia-Calvo, Margarita
    Bateman, Tom
    Xu, Ling
    Tong, Xinchun
    Crook, Martin
    Sinclair, Peter
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (15) : 4388 - 4392
12345